A detailed history of Beaton Management Co. Inc. transactions in Novartis Ag stock. As of the latest transaction made, Beaton Management Co. Inc. holds 8,873 shares of NVS stock, worth $980,998. This represents 0.51% of its overall portfolio holdings.

Number of Shares
8,873
Previous 8,873 -0.0%
Holding current value
$980,998
Previous $858,000 10.14%
% of portfolio
0.51%
Previous 0.47%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023

SELL
$80.03 - $92.81 $13,605 - $15,777
-170 Reduced 1.88%
8,873 $816,000
Q3 2022

Nov 14, 2022

SELL
$74.61 - $87.26 $35,514 - $41,535
-476 Reduced 5.0%
9,043 $687,000
Q1 2022

May 13, 2022

BUY
$80.11 - $90.62 $13,778 - $15,586
172 Added 1.84%
9,519 $835,000
Q3 2021

Nov 08, 2021

SELL
$81.78 - $95.14 $8,178 - $9,514
-100 Reduced 1.06%
9,347 $764,000
Q1 2021

May 14, 2021

SELL
$83.5 - $98.47 $18,871 - $22,254
-226 Reduced 2.34%
9,447 $808,000
Q4 2020

Feb 17, 2021

SELL
$78.07 - $94.43 $13,740 - $16,619
-176 Reduced 1.79%
9,673 $913,000
Q2 2020

Aug 14, 2020

BUY
$80.93 - $91.1 $12,139 - $13,665
150 Added 1.55%
9,849 $860,000
Q1 2020

May 15, 2020

BUY
$70.67 - $99.01 $8,763 - $12,277
124 Added 1.3%
9,699 $800,000
Q4 2019

Feb 07, 2020

BUY
$84.35 - $95.37 $1,012 - $1,144
12 Added 0.13%
9,575 $907,000
Q3 2019

Nov 15, 2019

BUY
$85.54 - $94.26 $6,843 - $7,540
80 Added 0.84%
9,563 $831,000
Q2 2019

Aug 15, 2019

SELL
$75.4 - $92.8 $6,559 - $8,073
-87 Reduced 0.91%
9,483 $866,000
Q1 2019

May 14, 2019

SELL
$75.32 - $86.15 $6,552 - $7,495
-87 Reduced 0.9%
9,570 $920,000
Q4 2017

Feb 07, 2018

SELL
$72.33 - $77.64 $5,424 - $5,823
-75 Reduced 0.77%
9,657 $811,000
Q3 2017

Nov 09, 2017

BUY
$74.14 - $77.27 $12,974 - $13,522
175 Added 1.83%
9,732 $835,000
Q2 2017

Aug 17, 2017

BUY
N/A
9,557
9,557 $798,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $238B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Beaton Management Co. Inc. Portfolio

Follow Beaton Management Co. Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Beaton Management Co. Inc., based on Form 13F filings with the SEC.

News

Stay updated on Beaton Management Co. Inc. with notifications on news.